Terry Heiman-Patterson
Overview
Explore the profile of Terry Heiman-Patterson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
666
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Helmold B, Nathaniel G, Barkhaus P, Bertorini T, Bromberg M, Brown A, et al.
Amyotroph Lateral Scler Frontotemporal Degener
. 2025 Mar;
:1-5.
PMID: 40084393
ALSUntangled reviews alternative and off-label treatments for people living with amyotrophic lateral sclerosis (PALS). In this review, we assess the utilization of dietary zinc supplements for modulating ALS pathology and...
2.
Berry J, Maragakis N, Macklin E, Chibnik L, Quintana M, Saville B, et al.
JAMA
. 2025 Mar;
PMID: 40067821
Importance: Bioenergetic failure has been proposed as a driver of amyotrophic lateral sclerosis (ALS). CNM-Au8 is a suspension of gold nanocrystals that catalyzes the conversion of nicotinamide adenine dinucleotide hydride...
3.
Shefner J, Oskarsson B, Macklin E, Chibnik L, Quintana M, Saville B, et al.
JAMA
. 2025 Mar;
PMID: 40067755
Importance: Amyotrophic lateral sclerosis (ALS) is a fatal disease. The sigma-1 (σ1) receptor emerged as a target for intervention. Objective: To determine the effects of pridopidine, a σ1-receptor agonist, in...
4.
Verdiperstat in Amyotrophic Lateral Sclerosis: Results From the Randomized HEALEY ALS Platform Trial
Andrews J, Paganoni S, Macklin E, Chibnik L, Quintana M, Saville B, et al.
JAMA Neurol
. 2025 Mar;
PMID: 40067754
Importance: Myeloperoxidase is one of the most abundant peroxidase enzymes in activated myeloid cells. Myeloperoxidase inhibitors may have a clinical benefit in amyotrophic lateral sclerosis (ALS) by slowing neurodegeneration via...
5.
Paganoni S, Fournier C, Macklin E, Chibnik L, Quintana M, Saville B, et al.
JAMA Netw Open
. 2025 Feb;
8(2):e2459058.
PMID: 39960672
Importance: The etiology of amyotrophic lateral sclerosis (ALS), a fatal neurodegenerative disease, is unknown. However, neuroinflammation and complement activation may play a role in disease progression. Objective: To determine the...
6.
Bakshi B, Yerraguntla S, Armon C, Barkhaus P, Bertorini T, Bowser R, et al.
Amyotroph Lateral Scler Frontotemporal Degener
. 2024 Dec;
:1-4.
PMID: 39709547
ALSUntangled reviews alternate and off-label treatments prompted by patient interest. Here, we review psilocybin, a chemical derived from mushrooms and belonging in the category of drugs known as psychedelics. Psilocybin...
7.
Dave K, Oskarsson B, Yersak J, Krauss R, Heiman-Patterson T, Lomen-Hoerth C, et al.
Amyotroph Lateral Scler Frontotemporal Degener
. 2024 Dec;
:1-10.
PMID: 39654532
To evaluate neurologists and other clinicians' contributions to U.S. ALS diagnostic timelines. : Over the past two decades, the average time to ALS diagnosis in the U.S. has remained unchanged...
8.
Ludolph A, Corcia P, Desnuelle C, Heiman-Patterson T, Mora J, Mansfield C, et al.
Muscle Nerve
. 2024 May;
70(1):36-41.
PMID: 38712849
The amyotrophic lateral sclerosis (ALS) functional rating scale-revised (ALSFRS-R) has become the most widely utilized measure of disease severity in patients with ALS, with change in ALSFRS-R from baseline being...
9.
Officer L, Armon C, Barkhaus P, Beauchamp M, Benatar M, Bertorini T, et al.
Amyotroph Lateral Scler Frontotemporal Degener
. 2024 Apr;
25(5-6):648-652.
PMID: 38666601
Spurred by patient interest, ALSUntangled herein examines the potential of the Portable Neuromodulation Stimulator (PoNS™) in treating amyotrophic lateral sclerosis (ALS). The PoNS™ device, FDA-approved for the treatment of gait...
10.
Jhooty S, Barkhaus P, Brown A, Cadavid J, Carter G, Crayle J, et al.
Amyotroph Lateral Scler Frontotemporal Degener
. 2024 Feb;
25(7-8):805-808.
PMID: 38318860
ALSUntangled reviews alternative and off-label treatments on behalf of people with ALS (PALS) who ask about them. Here, we review withania somnifera (WS) commonly known as ashwagandha or winter cherry....